Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)

Running, not enrolling · Not applicable

Conditions studied: Pulmonary Arterial Hypertension

In brief

The objectives of the RELIEVE-PAH study are to obtain first-in-human experience with the study device in patients with severe pulmonary arterial hypertension, including evidence of initial safety, device performance and possible signals of clinical effectiveness.

Key facts

Study ID

NCT03838445

Run by

V-Wave Ltd

People needed

9

Starts

2020-02-14

Expected to finish

2028-05-01

Last updated by the study team

2026-06-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Keck Medical Center of USC — Los Angeles, California, United States
• University of California, San Francisco — San Francisco, California, United States
• Instituto Nacional de Cardiologia — Mexico City, Mexico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.